Leukaemia Foundation

Change Your Location:


Myeloma: striving for a personalised approach to treatment is the focus of this year’s National Myeloma Day (NMD).

In looking forward, we also need to stop and look back ... to see just how far we have travelled.

The past decade has seen immense progress in understanding the disease itself and ongoing advances in its diagnosis, risk classification and management.

New agents developed over the last 10 years have changed the treatment landscape, resulting in greatly improved outcomes for people living with myeloma. 

With the expanding number of new agents being put to the test in clinical trials, researchers are moving closer to determining more accurate and targeted treatment decisions – thereby ‘striving for a personalised approach’.

"... myeloma management is not a ‘one size fits all’ approach ..."

These continual advances have shown myeloma management is not a ‘one size fits all’ approach, according to the Leukaemia Foundation’s National Myeloma Coordinator, Jo Beams.

“Awareness of different disease subgroups highlights the need for a targeted and more personalised approach to treatment,” Jo said.  

Clinical trials, which have been pivotal in improving treatment outcomes, will undoubtedly reveal the role of combination therapies, antibodies and new agents in forging better treatment options. 

“This will not be without challenges, with funding being a significant factor for consideration, as well as the day-to-day challenges people face living through multiple lines of treatment,” Jo said.

National Myeloma Day 2017 events

Providing information and support to people with myeloma and their families is an underlying objective of the National Myeloma Day activities being held across metro and regional Australia.

The Sydney, Melbourne, Adelaide and Perth events are organised co-jointly with the Myeloma Foundation of Australia.

“Our endeavour is that all our events provide the opportunity for people to meet together and gain support from others living with myeloma,” Jo said.

NMD activities on May 17 and throughout the month of May will provide the latest information on approved treatments in Australia, new and developing therapies, along with education on managing side-effects and ways to improve the day-to-day issues of living with myeloma.

People with myeloma and their family, friends or support people are encouraged to get involved in an event in their region.

Find out about activities in your region or call the Foundation on 1800 620 420.